IFN-α or β alone appears less effective for the treatment of HAM/TSP, but does show some therapeutic effects, especially during the early stages of HAM/TSP (Izumo et al., 1996; Saito et al., 2004). The gene discussed is IFNA2; the disease is tropical spastic paraparesis.